Exodus Point Capital Management, LP Inhibrx, Inc. Transaction History

Exodus Point Capital Management, LP

  • $14.7 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
BUY
$15.75 - $26.31 $172,588 - $288,304
10,958 New
10,958 $201,000
Q3 2022

Nov 10, 2022
SELL
$11.58 - $24.73 $778,558 - $1.66 Million
-67,233 Closed
0 $0
Q2 2022

Aug 19, 2022
BUY
$8.52 - $25.26 $572,825 - $1.7 Million
67,233 New
67,233 $763,000
Q4 2020

Feb 16, 2021
SELL
$15.96 - $50.0 $225,275 - $705,750
-14,115 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$16.77 - $20.65 $236,708 - $291,474
14,115 New
14,115 $254,000

Others Institutions Holding INBX

# of Institutions
2
Shares Held
25.3K
Call Options Held
0
Put Options Held
0
View Full List

About Inhibrx, Inc.

INBX Quotes by TradingView
  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $626M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email